Research ExplorerPublicationsGerman ablation registry: Cryoballoon vs. radiofrequency abl...

German ablation registry: Cryoballoon vs. radiofrequency ablation in paroxysmal atrial fibrillation--One-year outcome data

Standard

German ablation registry: Cryoballoon vs. radiofrequency ablation in paroxysmal atrial fibrillation--One-year outcome data. / Schmidt, Martin; Dorwarth, Uwe; Andresen, Dietrich; Brachmann, Johannes; Kuck, Karlheinz; Kuniss, Malte; Willems, Stephan; Deneke, Thomas; Tebbenjohanns, Jürgen; Gerds-Li, Jin-Hong; Spitzer, Stefan; Senges, Jochen; Hochadel, Matthias; Hoffmann, Ellen.

In: HEART RHYTHM, Vol. 13, No. 4, 04.2016, p. 836-844.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Schmidt, M, Dorwarth, U, Andresen, D, Brachmann, J, Kuck, K, Kuniss, M, Willems, S, Deneke, T, Tebbenjohanns, J, Gerds-Li, J-H, Spitzer, S, Senges, J, Hochadel, M & Hoffmann, E 2016, 'German ablation registry: Cryoballoon vs. radiofrequency ablation in paroxysmal atrial fibrillation--One-year outcome data', HEART RHYTHM, vol. 13, no. 4, pp. 836-844. https://doi.org/10.1016/j.hrthm.2015.12.007

APA

Schmidt, M., Dorwarth, U., Andresen, D., Brachmann, J., Kuck, K., Kuniss, M., Willems, S., Deneke, T., Tebbenjohanns, J., Gerds-Li, J-H., Spitzer, S., Senges, J., Hochadel, M., & Hoffmann, E. (2016). German ablation registry: Cryoballoon vs. radiofrequency ablation in paroxysmal atrial fibrillation--One-year outcome data. HEART RHYTHM, 13(4), 836-844. https://doi.org/10.1016/j.hrthm.2015.12.007

Vancouver

Schmidt M, Dorwarth U, Andresen D, Brachmann J, Kuck K, Kuniss M et al. German ablation registry: Cryoballoon vs. radiofrequency ablation in paroxysmal atrial fibrillation--One-year outcome data. HEART RHYTHM. 2016 Apr;13(4):836-844. https://doi.org/10.1016/j.hrthm.2015.12.007

Bibtex

@article{4cd7b3f2e07e44af812ddb73a909c4e2,
title = "German ablation registry: Cryoballoon vs. radiofrequency ablation in paroxysmal atrial fibrillation--One-year outcome data",
abstract = "BACKGROUND: Although radiofrequency (RF) ablation has long been the standard of care for atrial fibrillation (AF) ablation, cryoballoon technology has emerged as a feasible approach with promising results. Prospective multicenter registry data referring to both ablation technologies in AF ablation are lacking so far.OBJECTIVE: The purpose of this study was to report data from the German ablation registry with respect to efficacy and safety in pulmonary vein ablation with different energy sources for paroxysmal AF after 1-year follow-up.METHODS: A total of 2306 patients with symptomatic paroxysmal AF from the German ablation registry were included in this analysis. The cohort was divided into two groups according to the ablation energy source used: cryoballoon and RF ablation. MACCE was defined as a combination of death, myocardial infarction, or stroke.RESULTS: AF recurrence rate after a single ablation procedure at 1 year follow-up was not significantly different between the two groups (45.8% after cryoablation and 45.4% after RF ablation, P = .87). Also, the rate of patients without AF recurrence and free of antiarrhythmic drug at 12-month follow-up was similar (cryoablation 44.2% and RF 41.4%, P = .25). MACCE occurred with an incidence of 0.7% within 500 days after cryoablation and 1.4% after RF ablation (P = .30). Persistent phrenic nerve palsy was more common after cryoablation compared to RF ablation (1.1% vs. 0.3%, P <.05).CONCLUSION: AF recurrence rate at 1-year follow-up was similar in RF ablation compared to cryoablation, whereas the spectrum and relevance of complications were significantly different between the two ablation methods. This finding might influence the choice of ablation method offered to the individual paroxysmal AF patient.",
keywords = "Aged, Atrial Fibrillation/physiopathology, Catheter Ablation/methods, Cryosurgery/methods, Disease-Free Survival, Electrocardiography, Female, Follow-Up Studies, Germany/epidemiology, Heart Conduction System/physiopathology, Humans, Incidence, Male, Middle Aged, Postoperative Complications/epidemiology, Prognosis, Prospective Studies, Recurrence, Registries, Survival Rate/trends, Tachycardia, Paroxysmal/physiopathology, Treatment Outcome",
author = "Martin Schmidt and Uwe Dorwarth and Dietrich Andresen and Johannes Brachmann and Karlheinz Kuck and Malte Kuniss and Stephan Willems and Thomas Deneke and J{\"u}rgen Tebbenjohanns and Jin-Hong Gerds-Li and Stefan Spitzer and Jochen Senges and Matthias Hochadel and Ellen Hoffmann",
note = "Copyright {\textcopyright} 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.",
year = "2016",
month = apr,
doi = "10.1016/j.hrthm.2015.12.007",
language = "English",
volume = "13",
pages = "836--844",
journal = "HEART RHYTHM",
issn = "1547-5271",
publisher = "Elsevier",
number = "4",

}

RIS

TY - JOUR

T1 - German ablation registry: Cryoballoon vs. radiofrequency ablation in paroxysmal atrial fibrillation--One-year outcome data

AU - Schmidt, Martin

AU - Dorwarth, Uwe

AU - Andresen, Dietrich

AU - Brachmann, Johannes

AU - Kuck, Karlheinz

AU - Kuniss, Malte

AU - Willems, Stephan

AU - Deneke, Thomas

AU - Tebbenjohanns, Jürgen

AU - Gerds-Li, Jin-Hong

AU - Spitzer, Stefan

AU - Senges, Jochen

AU - Hochadel, Matthias

AU - Hoffmann, Ellen

N1 - Copyright © 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

PY - 2016/4

Y1 - 2016/4

N2 - BACKGROUND: Although radiofrequency (RF) ablation has long been the standard of care for atrial fibrillation (AF) ablation, cryoballoon technology has emerged as a feasible approach with promising results. Prospective multicenter registry data referring to both ablation technologies in AF ablation are lacking so far.OBJECTIVE: The purpose of this study was to report data from the German ablation registry with respect to efficacy and safety in pulmonary vein ablation with different energy sources for paroxysmal AF after 1-year follow-up.METHODS: A total of 2306 patients with symptomatic paroxysmal AF from the German ablation registry were included in this analysis. The cohort was divided into two groups according to the ablation energy source used: cryoballoon and RF ablation. MACCE was defined as a combination of death, myocardial infarction, or stroke.RESULTS: AF recurrence rate after a single ablation procedure at 1 year follow-up was not significantly different between the two groups (45.8% after cryoablation and 45.4% after RF ablation, P = .87). Also, the rate of patients without AF recurrence and free of antiarrhythmic drug at 12-month follow-up was similar (cryoablation 44.2% and RF 41.4%, P = .25). MACCE occurred with an incidence of 0.7% within 500 days after cryoablation and 1.4% after RF ablation (P = .30). Persistent phrenic nerve palsy was more common after cryoablation compared to RF ablation (1.1% vs. 0.3%, P <.05).CONCLUSION: AF recurrence rate at 1-year follow-up was similar in RF ablation compared to cryoablation, whereas the spectrum and relevance of complications were significantly different between the two ablation methods. This finding might influence the choice of ablation method offered to the individual paroxysmal AF patient.

AB - BACKGROUND: Although radiofrequency (RF) ablation has long been the standard of care for atrial fibrillation (AF) ablation, cryoballoon technology has emerged as a feasible approach with promising results. Prospective multicenter registry data referring to both ablation technologies in AF ablation are lacking so far.OBJECTIVE: The purpose of this study was to report data from the German ablation registry with respect to efficacy and safety in pulmonary vein ablation with different energy sources for paroxysmal AF after 1-year follow-up.METHODS: A total of 2306 patients with symptomatic paroxysmal AF from the German ablation registry were included in this analysis. The cohort was divided into two groups according to the ablation energy source used: cryoballoon and RF ablation. MACCE was defined as a combination of death, myocardial infarction, or stroke.RESULTS: AF recurrence rate after a single ablation procedure at 1 year follow-up was not significantly different between the two groups (45.8% after cryoablation and 45.4% after RF ablation, P = .87). Also, the rate of patients without AF recurrence and free of antiarrhythmic drug at 12-month follow-up was similar (cryoablation 44.2% and RF 41.4%, P = .25). MACCE occurred with an incidence of 0.7% within 500 days after cryoablation and 1.4% after RF ablation (P = .30). Persistent phrenic nerve palsy was more common after cryoablation compared to RF ablation (1.1% vs. 0.3%, P <.05).CONCLUSION: AF recurrence rate at 1-year follow-up was similar in RF ablation compared to cryoablation, whereas the spectrum and relevance of complications were significantly different between the two ablation methods. This finding might influence the choice of ablation method offered to the individual paroxysmal AF patient.

KW - Aged

KW - Atrial Fibrillation/physiopathology

KW - Catheter Ablation/methods

KW - Cryosurgery/methods

KW - Disease-Free Survival

KW - Electrocardiography

KW - Female

KW - Follow-Up Studies

KW - Germany/epidemiology

KW - Heart Conduction System/physiopathology

KW - Humans

KW - Incidence

KW - Male

KW - Middle Aged

KW - Postoperative Complications/epidemiology

KW - Prognosis

KW - Prospective Studies

KW - Recurrence

KW - Registries

KW - Survival Rate/trends

KW - Tachycardia, Paroxysmal/physiopathology

KW - Treatment Outcome

U2 - 10.1016/j.hrthm.2015.12.007

DO - 10.1016/j.hrthm.2015.12.007

M3 - SCORING: Journal article

C2 - 26681608

VL - 13

SP - 836

EP - 844

JO - HEART RHYTHM

JF - HEART RHYTHM

SN - 1547-5271

IS - 4

ER -